Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell

Cat. No.: X23-06-YM250

Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell

Synonym: ST3GAL4

Product Size
20 μg; 100 μg; 200 μg
Price
Datasheet
MSDS
Properties
Description
Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell plays a key role in the synthesis of sialyl Lewis x glycan epitope that may serve as ligands for E- and P-selectins on activated endothelial cells in inflammatory responses.
Molecular Weight
39-41 kDa
Source
Mouse myeloma cell
Form
Solution
Purity
>95%, determined by SDS-PAGE.
Applications
Recombinant human CMP -N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase from mouse myeloma cell is useful for the investigation of renal carcinoma.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0